Listed

Astrana Health, Inc.: Form 10-K/A for the period ended Dec 31, 2022

Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 17:24 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-10-01 to 2022-12-31$294.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue12 months2022-01-01 to 2022-12-31$1.14bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Operating income3 months2022-10-01 to 2022-12-31$12.6mus-gaap:OperatingIncomeLoss
Operating income12 months2022-01-01 to 2022-12-31$104.3mus-gaap:OperatingIncomeLoss
Interest expense12 months2022-01-01 to 2022-12-31$7.9mus-gaap:InterestExpense
Income tax3 months2022-10-01 to 2022-12-31$11.3mus-gaap:IncomeTaxExpenseBenefit
Income tax12 months2022-01-01 to 2022-12-31$40.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-10-01 to 2022-12-31−$3.7mus-gaap:NetIncomeLoss
Net income12 months2022-01-01 to 2022-12-31$45.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-10-01 to 2022-12-31−$0.08us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2022-01-01 to 2022-12-31$0.99us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-10-01 to 2022-12-31−$0.08us-gaap:EarningsPerShareBasic
Basic EPS12 months2022-01-01 to 2022-12-31$1.00us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2022-01-01 to 2022-12-3145,602,415 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2022-01-01 to 2022-12-31$82.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2022-01-01 to 2022-12-31$22.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2022-01-01 to 2022-12-31$14.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases12 months2022-01-01 to 2022-12-31$9.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-12-31$288.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$428.1mus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$966.2mus-gaap:Assets
Current liabilitiesAt period end2022-12-31$148.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$407.7mus-gaap:Liabilities
Long-term debtAt period end2022-12-31$203.4mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-12-31$619.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-12-31$542.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-23-028675. Last ingested by Listed: Nov 14, 2026, 19:58 ET. Listed shows no prices and gives no investment advice.